Inogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Loss per Share (Tables)

Loss per Share (Tables)

3 Months Ended

Mar. 31, 2024

The computation of EPS is as follows:


	Three months ended March 31,
	2024			2023
Numerator—basic and diluted:
Net loss	$	(14,578	)	$	(20,349	)

Denominator:
Weighted average common shares - basic common stock (1)		23,401,598			23,009,617
Weighted average common shares - diluted common stock		23,401,598			23,009,617

Net loss per share - basic common stock	$	(0.62	)	$	(0.88	)
Net loss per share - diluted common stock (2)	$	(0.62	)	$	(0.88	)

Denominator calculation from basic to diluted:
Weighted average common shares - basic common stock (1)		23,401,598			23,009,617
Stock options and other dilutive awards		267,100			228,281
Weighted average common shares - diluted common stock		23,668,698			23,237,898

Shares excluded from diluted weighted average shares:
Stock options		20,000			286,861
Restricted stock units and restricted stock awards		493,237			491,406
Shares excluded from diluted weighted average shares		513,237			778,267

(1)

Unvested restricted stock units and restricted stock awards are not included as shares outstanding in the calculation of basic earnings per share. Vested restricted stock units and restricted stock awards are included in basic earnings per share if all vesting and performance criteria have been met. Performance-based restricted stock units and restricted stock awards are included in the number of shares used to calculate diluted earnings per share as long as all applicable performance criteria are met, and their effect is dilutive. Restricted stock awards are eligible to receive all dividends declared on the Company’s common shares during the vesting period; however, such dividends are not paid until the restrictions lapse.

(2)

Due to net losses for the three months ended March 31, 2024 and March 31, 2023, diluted loss per share is the same as basic.